doi:10.3969/j.issn.1004-583X.2016.03.029

Abstract

CLC Number:

R563.9

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2016.03.029

https://huicui.hebmu.edu.cn/EN/Y2016/V31/I3/345

[1] Oswald-Mammosser M, Weitzenblum E, Quoix E, et al. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure[J]. Chest, 1995, 107(5): 1193-1198.
[2] Kessler R, Faller M, Fourgaut G, et al. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 1999, 159(1): 158-164.
[3] Idrees MM, Saleemi S, Azem MA, et al. Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: 2014 updates[J]. Ann Thorac Med, 2014, 9(Suppl 1):S1-S15.
[4] Minai OA, Chaouat A, Adnot S. Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective[J]. Chest, 2010, 137(6 Suppl):39S-51S.
[5] Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD[J]. Eur Respir J, 2008,32(5): 1371-1385.
[6] Hyduk A, Croft JB, Ayala C, et al. Pulmonary hypertension surveillance--United States, 1980-2002[J]. MMWR Surveill Summ, 2005, 54(5): 1-28.
[7] Thabut G, Dauriat G, Stern JB, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation[J]. Chest, 2005, 127(5): 1531-1536.
[8] Chaouat A, Bugnet AS, Kadaoui N, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2005, 172(2): 189-194.
[9] Yoshida T, Tuder RM. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease[J]. Physiol Rev, 2007, 87(3):1047-1082.
[10] Wright JL, Tai H, Churg A. Vasoactive mediators and pulmonary hypertension after cigarette smoke exposure in the guinea pig[J]. J Appl Physiol (1985), 2006, 100(2): 672-678.
[11] Zhao L, Wang J, Wang L, et al. Remodeling of rat pulmonary artery induced by chronic smoking exposure[J]. J Thorac Dis, 2014, 6(6): 818-828.
[12] Santos S, Peinado VI, Ramírez J, et al. Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD[J]. Eur Respir J, 2002, 19(4): 632-638.
[13] Hale KA, Ewing SL, Gosnell BA, et al. Lung disease in long-term cigarette smokers with and without chronic air-flow obstruction[J]. Am Rev Respir Dis, 1984, 130(5): 716-721.
[14] Peinado VI, Barberá JA, Abate P, et al. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 1999, 159(5 Pt 1):1605-1611.
[15] 张建全,钟小宁,蒋明,等. 慢支、肺气肿并肺动脉高压的特征及其机制探讨[J]. 广西医科大学学报, 2006,23(3): 375-378.
[16] Li J, Li JJ, He JG, et al. Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-κB pathway[J]. Cardiovasc Ther, 2010, 28(1): 8-14.
[17] Joppa P, Petrasova D, Stancak B, et al. Systemic inflammation in patients with COPD and pulmonary hypertension[J]. Chest, 2006, 130(2): 326-333.
[18] Eddahibi S, Chaouat A, Tu L, et al. Interleukin-6 gene polymorphism confers susceptibility to pulmonary hypertension in chronic obstructive pulmonary disease[J]. Proc Am Thorac Soc, 2006, 3(6): 475-476.
[19] Quarck R, Nawrot T, Meyns B, et al. C-reactive protein new predictor of adverse outcome in pulmonary arterial hypertension[J]. J Am Coll Cardiol, 2009, 53(14): 1211-1218.
[20] Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms[J]. Circ Res, 2006, 99(7): 675-691.
[21] Fishman AP. Hypoxia on the pulmonary circulation. How and where it acts[J]. Circ Res, 1976, 38(4): 221-231.
[22] Archer S, Michelakis E. The mechanism(s) of hypoxic pulmonary vasoconstriction potassium channels, redox O(2) sensors, and controversies[J]. News Physiol Sci, 2002,17: 131-137.
[23] 周荣,刘良明. 血管平滑肌肌浆网膜RyR2调节血管反应性的研究进展[J].生理科学进展, 2012,43(1):41-44.
[24] 胡颖,格日力. 离子通道在肺动脉的分布及在低氧肺血管收缩反应中的作用[J].生理科学进展, 2006,37(2): 113-116.
[25] Albarwani S, Heinert G, Turner JL, et al. Differential K⁺ channel distribution in smooth muscle cells isolated from the pulmonary arterial tree of the rat[J]. Biochem Biophys Res Commun, 1995, 208(1):183-189.
[26] 杨张娅,刘斌. ROCK信号通路在血管平滑肌细胞增殖和迁移作用中的研究进展[J].实用心脑肺血管病杂志, 2013, 21(3):10-12.
[27] Jin HG, Yamashita H, Nagano Y, et al. Hypoxia-induced upregulation of endothelial small G protein RhoA and Rho-kinase/ROCK2 inhibits eNOS expression[J]. Neurosci Lett, 2006, 408(1): 62-67.
[28] 王辰,杜敏捷,曹大德,等.慢性肺原性心脏病急性发作期肺细小动脉血栓形成的病理观察[J]. 中华医学杂志, 1997,77(2): 44-46+82.
[29] Timms RM, Khaja FU, Williams GW. Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease[J]. Ann Intern Med, 1985, 102(1): 29-36.
[30] Magee F, Wright JL, Wiggs BR, et al. Pulmonary vascular structure and function in chronic obstructive pulmonary disease[J]. Thorax, 1988, 43(3): 183-189.
[31] Wilkinson M, Langhorne CA, Heath D, et al. A pathophysiological study of 10 cases of hypoxic cor pulmonale[J]. Q J Med, 1988, 66(249): 65-85.
[32] Wang PP, Kong FP, Chen XQ, et al. HIF- 1 signal pathway in cellular response to hypoxia[J]. J Zhejiang Univ ( Medical Sci), 2011,40(5): 559- 566.
[33] Faller DV. Endothelial cell responses to hypoxic stress[J]. Clin Exp Pharmacol Physiol, 1999, 26(1): 74-84.
[34] 袁雅冬,宫小薇.2014年呼吸系统疾病临床进展[J].临床荟萃,2015,30(2):135-141.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	. [J]. Clinical Focus, 2024, 39(2): 188-192.
[2]	. [J]. Clinical Focus, 2023, 38(8): 749-752.
[3]	. [J]. Clinical Focus, 2022, 37(11): 1048-1052.
[4]	Sun Ying, Yu Qin. Long-term effect of hypoglossal nerve stimulation in the treatment of obstructive sleep apnea hypopnea syndrome: A meta analysis [J]. Clinical Focus, 2022, 37(8): 677-684.
[5]	Wang Xuefeng. Clinical correlation between fatigue and multi-dimensional indexes in patients with stable moderate chronic obstructive pulmonary disease [J]. Clinical Focus, 2022, 37(8): 704-707.
[6]	Zhang Zhiping, Zhang Baomin, Qin Wei, Gao Lingjie, Chen Dong. Clinical application of nutritional support on mechanical ventilation in acute exacerbation of chronic obstructive pulmonary disease [J]. Clinical Focus, 2022, 37(6): 510-514.
[7]	. [J]. Clinical Focus, 2021, 36(9): 861-864.
[8]	Fu Qun, Guo Di, Zhao Wenfei. VEGF, ICAM-1, IL-13, FeNO level of induced sputum on asthma, asthma-copd overlap, and chronic obstructive pulmonary disease in patients: clinical changes and significance [J]. Clinical Focus, 2021, 36(6): 513-516.
[9]	Zhang Qinxia, a, Zhang Haifu, b, Lyu Quna. Efficacy and safety of ticagrelor in coronary artery disease and chronic obstructive pulmonary disease: a metaanalysis [J]. Clinical Focus, 2020, 35(11): 965-970.
[10]	Lu Qiuxia;Chen Xi;Wu Xiao;Hu Shanyou;Wang Li. Plasma N-terminal B-type natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease patients and prognosis [J]. Clinical Focus, 2015, 30(11): 1265-1268.
[11]	. [J]. Clinical Focus, 2015, 30(9): 1063-1066.
[12]	. @@ [J]. Clinical Focus, 2015, 30(8): 956-960.
[13]	Zhang Zhen;Jia Shiqiang;Peng Zhanxian;Zong Wei;Wen Shiwei;Sun Luhua;Rong Xuebing;Wang Jingjun;Dong Shimin. Clinical value of rapid shallow breathing index in predicting ventilator weaning in sleeping patients with acute exacerbation chronic obstructive pulmonary disease [J]. Clinical Focus, 2015, 30(5): 506-508509.
[14]	. [J]. Clinical Focus, 2015, 30(5): 564-566.
[15]	Hu Shanshan;Zhang Shun;Cai Ting. Immunochemotherapy for advanced non-small cell lung cancer:a meta-analysis [J]. Clinical Focus, 2015, 30(3): 283-289.